For the treatment of HBV infection with normal ALT (alanine aminotransferase), antiviral therapy is recommended in patients > 30-years-old with a family history of liver cirrhosis or cancer in the 2019 China guidelines. The gene discussed is GPT; the disease is cirrhosis of liver.